Register for our free email digests:
Convergence Pharmaceuticals Ltd
http://www.convergencepharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Convergence Pharmaceuticals Ltd
Appointments: Almirall, Axial, Therachon, Theranexus, Carrick and Karolinksa
This week's roundup includes Almirall's appointment of a former Sanofi employee as CEO and various other high-level appointments by Axial, Therachon, Theranexus and Karolinska.
Quartet Medicine Inc.
Quartet Medicine Inc.'s pipeline of novel small-molecule drugs to address chronic pain and inflammation target the tetrahydrobiopterin (BH4) synthesis pathway, a target with genetic and pharmacological links to regulating human disease at the intersection of the peripheral nervous system and the immune system. The start-up thinks its approach has the potential to provide improved efficacy without the side effects associated with existing centrally acting analgesics.
Biogen CEO Scangos On Alzheimer's, Multiple Sclerosis – And Pricing
George Scangos talks about the tradeoffs that drug pricing requires, and the logistical challenges that a blockbuster Alzheimer's product would create.
Astellas, Chromocell In Pain Pact Worth $515m-plus
Astellas will pay Chromocell $15m up front and could spend more than $500m on milestone fees under a license and collaboration agreement for Nav1.7 antagonists, including lead drug candidate CC8464 and backup compounds, for the treatment of neuropathic pain and other conditions.
Company Information
- Other Names / Subsidiaries
-
- Calchan Holdings Limited